dr. sartor on patients in the alsympca radium-223 trial
Published 12 years ago • 408 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
1:25
dr. sartor discusses the novel agent radium-223
-
1:24
dr. sartor on mechanism of action and safety of radium-223 in mcrpc
-
1:08
dr. sartor on provenge in combination with radium-223
-
1:08
dr. a. oliver sartor on the mechanism of action of radium-223
-
1:38
dr. sartor on outcomes with 177lu-psma-617 after radium-223 in mcrpc
-
19:52
a medical oncologist compares surgery and radiation for prostate cancer | mark scholz, md | pcri
-
11:56
treating lymph node metastases #prostatecancer | #markscholzmd | #alexscholz #pcri
-
8:27
ra223 treatment for prostate cancer
-
1:04
dr. oliver sartor discusses radium-223 in early prostate cancer
-
1:41
dr. oliver sartor on doubling the dosage of radium-223 in patients with crpc
-
2:25
sartor: expanded access program for radium-223 (xofigo)
-
1:05
oliver sartor discusses common questions about radium-223
-
3:52
incorporating radium 223 in community practice
-
1:20
dr. sartor on provenge in combination with radium-223
-
0:53
dr. sartor on impact of radium-223 for community oncologists
-
0:47
dr. oliver sartor discusses a new prostate cancer trial combining radium-223 and provenge
-
0:42
oliver sartor discusses clinical use of radium-223
-
1:25
dr. sartor on progress for the treatment of prostate cancer
-
8:45
era 223 study | concerns for using radium-223 and abiraterone
-
1:07
dr. luke nordquist on radium-223 retreatment
-
1:30
dr. sartor on the vision trial in mcrpc
-
1:10
dr. dreicer on challenges of radium-223 in prostate cancer